These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27016506)

  • 1. Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review.
    Suarato G; Li W; Meng Y
    Biointerphases; 2016 Dec; 11(4):04B201. PubMed ID: 27016506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
    Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
    Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR; Sunil D
    Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layer-by-layer nanoparticle platform for cancer active targeting.
    Suh MS; Shen J; Kuhn LT; Burgess DJ
    Int J Pharm; 2017 Jan; 517(1-2):58-66. PubMed ID: 27923697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
    Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
    Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of pH-Sensitive interactions between podophyllotoxin-chitosan for enhanced controlled drug release.
    Chen C; Yu Y; Wang X; Shi P; Wang Y; Wang P
    Int J Biol Macromol; 2017 Feb; 95():451-461. PubMed ID: 27867056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor targeting strategies for chitosan-based nanoparticles.
    Zhang X; Yang X; Ji J; Liu A; Zhai G
    Colloids Surf B Biointerfaces; 2016 Dec; 148():460-473. PubMed ID: 27665379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
    Vivek R; Nipun Babu V; Thangam R; Subramanian KS; Kannan S
    Colloids Surf B Biointerfaces; 2013 Nov; 111():117-23. PubMed ID: 23787278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Progress of Chitosan-based Multifunctional Nanoparticles in Cancer Targeted Therapy.
    Lai C; Lin S; Liu W; Jin Y
    Curr Med Chem; 2024; 31(21):3074-3092. PubMed ID: 37062062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
    Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
    J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
    Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
    Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-responsive drug-delivery systems.
    Zhu YJ; Chen F
    Chem Asian J; 2015 Feb; 10(2):284-305. PubMed ID: 25303435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile solvothermal synthesis of mesostructured Fe3O4/chitosan nanoparticles as delivery vehicles for pH-responsive drug delivery and magnetic resonance imaging contrast agents.
    Zhao G; Wang J; Peng X; Li Y; Yuan X; Ma Y
    Chem Asian J; 2014 Feb; 9(2):546-53. PubMed ID: 24259489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.